DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
- Operating income, 2025
- −$468M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$468M | — |
| 2024 | −$344M | — |
| 2023 | −$242M | — |
| 2022 | −$171M | — |
| 2021 | −$150M | — |
| 2020 | −$59M | — |
| 2019 | −$14M | — |